Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding

키워드

참고문헌 (32)

1. Lee SR, "Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population", Int J Cardiol, 236, pp.226~231 (2017)
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation, "Analysis of pooled data from five randomized controlled trials", Arch Intern Med, 154, pp.1449~1457 (1994)
3. Bungard TJ, "Why do patients with atrial fibrillation not receive warfarin", Arch Intern Med, 160, pp.41~46 (2000)
4. Chang SH, "Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation", JAMA, 318, pp.1250~1259 (2017)
5. Zhang Y, "Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs : a population-based nested case-control study", Br J Clin Pharmacol, 86, pp.1150~1164 (2020)
6. Jobski K, "Drug interactions with oral anticoagulants in German nursing home residents : comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case-control studies", Clin Res Cardiol, 109, pp.465~475 (2020)
7. Schjerning Olsen AM, "Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation : a nationwide study", Eur Heart J Cardiovasc Pharmacother (2019)[DOI]
8. Kent AP, "Concomitant oral anticoagulant and nonsteroidal anti-inflammatory drug therapy in patients with atrial fibrillation", J Am Coll Cardiol, 72, pp.255~267 (2018)
9. Renoux C, "Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage", JAMA Neurol, 74, pp.173~180 (2017)
10. Cheng YL, "Use of SSRI, but not SNRI, increased upper and lower gastrointestinal bleeding: a nationwide population-based cohort study in Taiwan", Medicine (Baltimore), 94, pp.e2022~ (2015)
11. Shin JY, "Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs : nationwide propensity score matched study", BMJ, 351, pp.h3517~ (2015)
12. Bixby AL, "Clinical management of bleeding risk with antidepressants", Ann Pharmacother, 53, pp.186~194 (2019)
13. Steffel J, "The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation", Eur Heart J, 39, pp.1330~1393 (2018)
14. Schulman S, "Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients", J Thromb Haemost, 3, pp.692~694 (2005)
15. Wacholder S, "Selection of controls in case-control studies. III. Design options", Am J Epidemiol, 135, pp.1042~1050 (1992)
16. Essebag V, "Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure", BMC Med Res Methodol, 5, pp.5~ (2005)
17. Forbes HL, "Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients", Ther Adv Drug Saf, 8, pp.319~328 (2017)
18. Sun‐Young Jung, "Effect of a Nationwide Real‐Time Drug Utilization Review System on Duplicated Nonsteroidal Antiinflammatory Drug Prescriptions in Korea", Arthritis Care & Research, 72(10), pp.1374~1382 (2020), Wiley[DOI]
19. Quan H, "Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data", Med Care, 43, pp.1130~1139 (2005)
20. Olesen JB, "Bleeding risk in ‘real world’ patients with atrial fibrillation : comparison of two established bleeding prediction schemes in a nationwide cohort", J Thromb Haemost, 9, pp.1460~1467 (2011)
21. Lanas Á, "Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants", Clin Gastroenterol Hepatol, 13, pp.906~912 (2015)
22. Schafer AI, "Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis", J Clin Pharmacol, 35, pp.209~219 (1995)
23. de Abajo FJ, "Effects of selective serotonin reuptake inhibitors on platelet function : mechanisms, clinical outcomes and implications for use in elderly patients", Drugs Aging, 28, pp.345~367 (2011)
24. Bykov K, "Impact of an interaction between clopidogrel and selective serotonin reuptake inhibitors", Am J Cardiol, 119, pp.651~657 (2017)
25. Andrade C, "Serotonin reuptake inhibitors and risk of abnormal bleeding", Psychiatr Clin North Am, 39, pp.413~426 (2016)
26. Maiden L, "Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel : a cross-sectional capsule enteroscopy study", Clin Gastroenterol Hepatol, 5, pp.1040~1045 (2007)
27. Boguta P, "Safety of concomitant treatment with non-vitamin K oral anticoagulants and SSRI", SNRI antidepressants, 2018, pp.19, 267~278
28. Yuet WC, "Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding", J Am Osteopath Assoc, 119, pp.102~111 (2019)
29. Patel S, "Dabigatran-induced acute interstitial nephritis : an important complication of newer oral anticoagulation agents", J Clin Med Res, 10, pp.791~794 (2018)
30. Monahan RC, "A case of rivaroxabanassociated acute tubulointerstitial nephritis", Neth J Med, 75, pp.169~171 (2017)
31. Hansen ML, "Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation", Arch Intern Med, 170, pp.1433~1441 (2010)
32. Heidenreich PA, "2016 ACC", AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter : a report of the American College of Cardiology, Circ Cardiovasc Qual Outcomes, pp.2016, 9[DOI]

관련 논문AI추천